Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

NOVEL-1 st : A Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Hwang Wen-Li, MD, Tsung-Chih Chen, MD, Shyuann-Yuh Lin, MD, Ming-Chih Chang, MD, Pei-Ching Hsiao, MD, Li-Yuan Bai, PhD, Ching-Yuan Kuo, Yeu-Chin Chen, MD, Ta-Chih Liu, MD PhD, Jyh-Pyng Gau, MD, Po-Nan Wang, MD, Chieh-Wen Chen, Yee-Ming Lee, PhD, Fan-Chen Ku, MD, Jih-Luh Tang, MD, PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137327

Published: 2020

Journal Articles

Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

Hsin-An Hou, Chien-Chin Lin, MD, Ming-Chung Kuo, MD, Shyuann-Yuh Lin, MD, Jyh-Pyng Gau, MD, Ming-Chung Wang, MD, Ming-Chih Chang, MD, Tsung-Chih Chen, MD, Su-Peng Yeh, MD, Yeu-Chin Chen, MD, Cih-En Huang, MD, Chieh-Wen Chen, MD, Yee-Ming Lee, PhD, Fan-Chen Ku, MD, Lee-Yung Shih, MD

Blood (2019) 134 (Supplement_1): 5374.

https://doi.org/10.1182/blood-2019-129645

Published: 2019

Journal Articles

Acquired Resistance to JAK Inhibitors in Calr-Mutated Myeloproliferative Neoplasms

Ken-Hong Lim, MD, Yu-Cheng Chang, MD, Yi-Hao Chiang, MD, Huan-Chau Lin, MD, Ling Huang, MSc, Wei-Ting Wang, MSc, Ying-Wen Su, MD, PhD, Ming-Chih Chang, MD, Yi-Fang Chang, MD PhD, Caleb Gon-Shen Chen, MD PhD

Blood (2019) 134 (Supplement_1): 2970.

https://doi.org/10.1182/blood-2019-124420

Published: 2019

Journal Articles

NOVEL-1 st : Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Hwang Wen-Li, MD, Shao-Min Han, MD, Shyuann-Yuh Lin, MD, Ming-Chih Chang, MD, Li-Yuan Bai, PhD, Pei-Ching Hsiao, MD, Ching-Yuan Kuo, Yeu-Chin Chen, MD, Ta-Chih Liu, MD PhD, Po-Nan Wang, MD, Jyh-Pyng Gau, MD, Yee-Ming Lee, PhD, Fan-Chen Ku, Jih-Luh Tang, MD

Blood (2018) 132 (Supplement 1): 3019.

https://doi.org/10.1182/blood-2018-99-112342

Published: 2018

Journal Articles

Distinct Microrna Profiles in Patients with Essential Thrombocythemia: Clinical and Prognostic Correlation

Yi-Hao Chiang, MD, Yu-Cheng Chang, MD, Huan-Chau Lin, MD, Ling Huang, MSc, Chun-Chia Cheng, PhD, Nai-Wen Su, MD, Caleb Gon-Shen Chen, MD PhD, Johnson Lin, MD, Ruey-Kuen Hsieh, MD, Ming-Chih Chang, MD, Yi-Fang Chang, MD PhD, Wei-Ming Chen, Shih-Ting Kang, Yu-Shan Huang, Jian-Yi Lin, Tiffany Wang, Ken-Hong Lim, MD

Blood (2018) 132 (Supplement 1): 3045.

https://doi.org/10.1182/blood-2018-99-114921

Published: 2018

Journal Articles

A Retrospective Multicenter Study to Evaluate the Efficacy of Rabbit Antithymocyte Globulin (rATG) Immunosuppressive Therapy As First-Line Treatment of Aplastic Anemia

Suporn Chuncharunee, MD, Raymond SM Wong, MD, Ponlapat Rojnuckarin, MD PhD, Cheng-Shyong Chang, MD, Kian Meng Chang, MD, Meng-Yao Lu, MD, Wen-Li Hwang, MD, Liang Piu Koh, MD, Tsai-Yun Chen, MD, Anskar YH Leung, MD, Lalita Norasetthada, MD, Shih-Chung Wang, MD, Ming-Chih Chang, MD, Kang-Hsi Wu, MD, Surapol Issaragrisil, MD

Blood (2015) 126 (23): 1217.

https://doi.org/10.1182/blood.V126.23.1217.1217

Published: 2015

Journal Articles

Different Adverse Event Profiles and Significant Hematological Improvement Are Noted When Deferasirox Was Used in Adult Patients with Chronic Transfusion-Related Iron Overload in Taiwan: Results from a Prospective Observational Clinical Trial

Bor-Sheng Ko, Ming-Chih Chang, MD, Tzeon-Jye Chiou, MD, Te-Kau Chang, MD, Yeu-Chin Chen, MD, Sheng-Fung Lin, MD, Cheng-Shyong Chang, MD, Yin-Che Lu, MD, Su-Peng Yeh, MD, Tsai-Yun Chen, MD, Wei-Yu Chen, MD

Blood (2015) 126 (23): 4554.

https://doi.org/10.1182/blood.V126.23.4554.4554

Published: 2015

Journal Articles

B Cell Immune Profiles in Essential Thrombocythemia with Calr Mutations: Clinical and Molecular Correlates

Yu-Cheng Chang, MD, Ken-Hong Lim, MD, Huan-Chau Lin, MD, Yi-Hao Chiang, MD, Ling Huang, MSc, Chen-Wei Kao, Chiao-Yi Chang, MSc, Ching-Sung Lin, MSc, Nai-Wen Su, MD, Johnson Lin, MD MPH, Ruey-Kuen Hsieh, MD, Ming-Chih Chang, MD, Yi-Fang Chang, MD PhD, Caleb Gon-Shen Chen, MD PhD, Yuan-Yeh Kuo, PhD, Wen-Chien Chou, MD PhD

Blood (2015) 126 (23): 1610.

https://doi.org/10.1182/blood.V126.23.1610.1610

Published: 2015

Journal Articles

Safety and Efficacy of Nilotinib (NIL) in Patients (Pts) with Chronic Phase (CP) or Accelerated Phase (AP) Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) with Resistance or Intolerance to Imatinib Mesylate (IM): Results from the Multicenter, Observational NOVEL Study in Taiwan

Ching-Yuan Kuo, MD, Po-Nan Wang, MD, Wen Li Hwang, MD, Cheng-Hwai Tzeng, MD, Li-Yuan Bai, MD, Jih-Luh Tang, MD PhD, Ming-Chih Chang, MD, Sheng-Fung Lin, MD, Tsai-Yun Chen, MD, Yeu-Chin Chen, MD, Tran-Der Tan, MD, Chih-Yi Hseih, MD, Chinjune Lin, MD, Miljkovic Darko, MD, Chang Cheng-Shyong, MD

Blood (2015) 126 (23): 1593.

https://doi.org/10.1182/blood.V126.23.1593.1593

Published: 2015

Journal Articles

Calr Mutations in Essential Thrombocythemia: Frequency, Clinical Correlation and Screening By High-Resolution Melting Analysis

Ken-Hong Lim, MD, Huan-Chau Lin, MD, Yi-Hao Chiang, MD, Wei-Ting Wang, MSc, Ching-Sung Lin, MSc, Yu-Cheng Chang, MD, Nai-Wen Su, MD, Caleb Gon-Shen Chen, MD PhD, Johnson Lin, MD, Ruey-Kuen Hsieh, MD, Ming-Chih Chang, MD, Yi-Fang Chang, MD, Yuan-Yeh Kuo, PhD, Wen-Chien Chou, MD PhD

Blood (2014) 124 (21): 1838.

https://doi.org/10.1182/blood.V124.21.1838.1838

Published: 2014

Journal Articles

A National Registry of Patients Diagnosed with Multiple Myeloma in Taiwan.

Tzeon-Jye Chiou, MD, Shang-Yi Huang, MD, PhD, Cheng-Shyong Chang, MD, Sheng-Fung Lin, MD, Sung-Nan Pei, MD, Chang-Fang Chiu, MD, DMS, Ching-Liang Ho, Ming-Chih Chang, MD, Tran-Der Tan, MD, Liang-Tsai Hsiao, MD

Blood (2009) 114 (22): 4955.

https://doi.org/10.1182/blood.V114.22.4955.4955

Published: 2009

NARROW

NOVEL-1 st : A Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

Acquired Resistance to JAK Inhibitors in Calr-Mutated Myeloproliferative Neoplasms

NOVEL-1 st : Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Distinct Microrna Profiles in Patients with Essential Thrombocythemia: Clinical and Prognostic Correlation

A Retrospective Multicenter Study to Evaluate the Efficacy of Rabbit Antithymocyte Globulin (rATG) Immunosuppressive Therapy As First-Line Treatment of Aplastic Anemia

Different Adverse Event Profiles and Significant Hematological Improvement Are Noted When Deferasirox Was Used in Adult Patients with Chronic Transfusion-Related Iron Overload in Taiwan: Results from a Prospective Observational Clinical Trial

B Cell Immune Profiles in Essential Thrombocythemia with Calr Mutations: Clinical and Molecular Correlates

Calr Mutations in Essential Thrombocythemia: Frequency, Clinical Correlation and Screening By High-Resolution Melting Analysis

A National Registry of Patients Diagnosed with Multiple Myeloma in Taiwan.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only